Please contact us for more information or to learn if you are eligible to participate.
To analyze biomarkers in whole blood of ulcerative colitis or Crohn’s disease patients. This research may result in the development of a commercial pharmaceutical product, including but not limited to therapeutic agents, unique cell lines, and/or new and better treatments for your condition.
Dr. Sohail Rao
Type of Trial